Related Experiment Video
Updated: May 29, 2026

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
The breast screening programme and misinforming the public
Peter C Gøtzsche1, Karsten Juhl Jørgensen
1The Nordic Cochrane Centre, Copenhagen, Denmark. pcg@cochrane.dk
Abstract:
The information provided to the public by the NHS Breast Screening Programme has been criticized for lack of balance, omission of information on harms and substantially exaggerated estimates of benefit. These shortcomings have been particularly evident in the various invitation leaflets for breast screening and in the Programme's own 2008 Annual Review, which celebrated 20 years of screening. The debate on screening has been heated after new data published in the last two years questioned the benefit and documented substantial harm. We therefore analysed whether the recent debate and new pivotal data about breast screening has had any impact on the contents of the new 2010 leaflet and on the 2010 Annual Review. We conclude that spokespeople for the Programme have stuck to the beliefs about benefit that prevailed 25 years ago. Concerns about over-diagnosis have not been addressed either and official documents still downplay this most important harm of breast cancer screening.
Insights
Information on breast cancer screening benefits and harms remains unbalanced. Official NHS Breast Screening Programme documents from 2010 still downplay over-diagnosis, a significant harm, despite new data and ongoing debate.
Area of Science:
- Public Health
- Medical Screening
- Health Communication
Background:
- The NHS Breast Screening Programme has faced criticism regarding the balance of information on benefits and harms.
- Recent data and debate have questioned the established benefits and highlighted significant harms of breast cancer screening.
Purpose of the Study:
- To analyze the impact of recent data and debate on the 2010 NHS Breast Screening Programme leaflet and Annual Review.
- To assess if concerns about over-diagnosis and other harms have been addressed in official communications.
Main Methods:
- Content analysis of the 2010 NHS Breast Screening Programme leaflet.
- Content analysis of the 2010 NHS Breast Screening Programme Annual Review.
- Comparison with previous Programme communications and recent scientific data.
Main Results:
- Official documents and communications from the Programme have not significantly changed.
- Established beliefs regarding screening benefits persist, unchanged for over 25 years.
- Concerns about over-diagnosis, a major harm, remain unaddressed and downplayed.
Conclusions:
- The NHS Breast Screening Programme's communication strategy has not evolved to reflect current evidence on harms and benefits.
- Official documents continue to present an unbalanced view, overestimating benefits and underestimating harms like over-diagnosis.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Preventive Healthcare Services
Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters assessment...
Cancer Prevention
Some...
Radiological Investigation I: X-ray and CT
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
